Advances in Pain Management (Vol. 2, No. 1)

Faculty

Needs Statement

Advances in Pain Management, a CME-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of pain management. It provides rapid access for busy specialists (including pain specialists, anesthesiologists, neurologists, oncologists, general physicians, and primary care physicians) to a critical and clinically relevant review of the developments that will have most impact on their day-to-day practice and is designed to provide management options for clinicians to allow them to better diagnose and treat patients suffering chronic pain.

Each issue of Advances in Pain Management will present carefully constructed leading (review) articles, written by practicing pain specialists, and intended to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editor-in-Chief, Editorial team and readers. This issue of Advances in Pain Management presents three such leading articles.

Target Audience

This activity is designed to meet the educational needs of multidisciplinary clinicians and healthcare professionals involved in the care of patients with chronic pain.

Objectives

After reading all three articles the reader should be able to discuss:
1. Opioid-specific screening tools;
2. Risk factors associated with opioid addiction;
3. The reservations clinicians have in making these prescriptions;
4. Risk assessment in patients taking opioids;
5. Opioid analgesic-associated risks and benefits;
6. How prescription drug abuse may arise.

Accreditation

Medicine
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and Remedica Medical Education. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Each physician should claim only those hours of credit actually spent in the educational activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

Dr. Webster has received research support and/or consultant fees from Abbott, Advanced Bionic, Alpharma Pharmaceuticals, LLC, Ameritox, Arrya, AstraZeneca, Boehringer Ingelheim, Cephalon, CoMentis, Covidien, Durect, Elan, Elite, Forest, GlaxoSmithKline, Jazz, King Pharmaceutical, Medtronic, Merck, Nektar, Nervo, NeurogesX , Orthocon, Pain Therapeutics, Inc., Predix, Purdue, QRx Pharma, Respironics, Takeda, Torreypines, Wyeth and Zars.

Drs. Passik and Kirsh report no relevant financial relationships with commercial interests of healthcare products or services related to this activity.

Dr. Cicero reports no relevant financial relationships with commercial interests of healthcare products or services related to this activity.

Disclosures for the Editorial Board can be found inside the PDF.

Activity Sponsorship

This activity is jointly sponsored by the University of Kentucky and Remedica Medical Education. Supported by an unrestricted educational grant from Cephalon.